SLC24A6 antibody Western blot of 721_B cell lysate. This image was taken for the unconjugated form of this product. Other forms have not been tested.
SLC8B1 / SLC24A6 / NCLX Antibody (aa468-517)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general), Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$433.00each
Catalog Number: LS-C102072-100
Catalog Number: LS-C102072
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- NCLX antibody LS-C102072 is an unconjugated rabbit polyclonal antibody to human NCLX (SLC8B1 / SLC24A6) (aa468-517). Validated for WB. Cited in 1 publication.
- Application
- ELISA, IHC, WB
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- NCKX6 | NCLX | SLC24A6
- UniProt Number
- Q6J4K2
- NCBI GenBank
- NM_024959 | NP_079235.2
- SwissProt
- Q6J4K2
Target
- Target
- Human SLC8B1 / SLC24A6 / NCLX
- Antigen Species
- Human
- Epitope
- Human SLC24A6
- Gene Name
- SLC8B1
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
- Isotype
- IgG
Immunogen
- Immunogen
- Synthetic peptide located between aa468-517 of human SLC8B1 (Q6J4K2, NP_079235). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Galago, Marmoset, Mouse, Rat, Dog, Bovine, Bat, Rabbit, Horse, Pig, Guinea pig (100%); Elephant (92%); Xenopus (91%); Zebra finch, Chicken, Stickleback (84%).
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, 0.09% sodium azide, 2% sucrose
- Concentration
- 0.5 mg/mL
- Volume
- 100 Microliter
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Short term: Store at 2-8°C. Long term: Aliquot and store at -20°C. Avoid freeze/thaw cycles.
- Recommended Storage Buffer
- PBS
PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia. Laura Rodríguez-Pascau, Elena Britti, Pablo Calap-Quintana, Yi Na Dong, Cristina Vergara, Fabien Delaspre, Marta Medina-Carbonero, Jordi Tamarit, Federico V Pallardó, Pilar Gonzalez-Cabo, Joaquim Ros, David R Lynch, Marc Martinell, Pilar Pizcueta. Neurobiology of disease. 2021 January;148:105162. PubMed: 33171227